Skip to main content
OX

Oxford Cancer Biomarkers

Oxford, United Kingdom
Last funding
Undisclosed
Venture - Series UnknownApr 2023

Oxford Cancer is developing and commercialising a suite of colorectal cancer biomarker tests to improve the current treatment pathway.

Backed byLongwall VentureNHS EnglandPanacea CapitalEsperante VenturesKwang Dong Pharmaceutical

About Oxford Cancer Biomarkers

Who are Oxford Cancer Biomarkers's investors?

Oxford Cancer Biomarkers's investors include Longwall Venture, NHS England, Panacea Capital, Esperante Ventures, Kwang Dong Pharmaceutical.

Where is Oxford Cancer Biomarkers headquartered?

Oxford Cancer Biomarkers is headquartered in Oxford, United Kingdom.

What does Oxford Cancer Biomarkers do?

Oxford Cancer is developing and commercialising a suite of colorectal cancer biomarker tests to improve the current treatment pathway.

What stage is Oxford Cancer Biomarkers at?

Oxford Cancer Biomarkers is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Oxford Cancer Biomarkers — Funding & Investors." VCBacked, April 3, 2023, https://www.vcbacked.co/company/oxford-cancer-biomarkers. Accessed November 13, 2026.
APA
VCBacked. (2023). Oxford Cancer Biomarkers — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/oxford-cancer-biomarkers
Wikipedia (cite web)
{{cite web |title=Oxford Cancer Biomarkers — Funding & Investors |url=https://www.vcbacked.co/company/oxford-cancer-biomarkers |website=VCBacked |access-date=November 13, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Oxford Cancer Biomarkers? Request a listing update

Founder contacts
m***@oxfordbio.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →